These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10780984)

  • 41. Evidence that quinolinic acid severely impairs energy metabolism through activation of NMDA receptors in striatum from developing rats.
    Ribeiro CA; Grando V; Dutra Filho CS; Wannmacher CM; Wajner M
    J Neurochem; 2006 Dec; 99(6):1531-42. PubMed ID: 17230642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Domoic acid, the alleged "mussel toxin," might produce its neurotoxic effect through kainate receptor activation: an electrophysiological study in the dorsal hippocampus.
    Debonnel G; Beauchesne L; de Montigny C
    Can J Physiol Pharmacol; 1989 Jan; 67(1):29-33. PubMed ID: 2540893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulation and function of kynurenic acid in the immature rat brain.
    Schwarcz R; Ceresoli-Borroni G; Wu HQ; Rassoulpour A; Poeggeler B; Hodgkins PS; Guidetti P
    Adv Exp Med Biol; 1999; 467():113-23. PubMed ID: 10721048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 7-chlorokynurenic acid prevents in vitro epileptiform and neurotoxic effects due to kainic acid.
    Domenici MR; Longo R; Sagratella S
    Gen Pharmacol; 1996 Jan; 27(1):113-6. PubMed ID: 8742506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine.
    Forrest CM; McNair K; Pisar M; Khalil OS; Darlington LG; Stone TW
    Neuroscience; 2015 Dec; 310():91-105. PubMed ID: 26365611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of orally administered guanosine on seizures and death induced by glutamatergic agents.
    Lara DR; Schmidt AP; Frizzo ME; Burgos JS; Ramírez G; Souza DO
    Brain Res; 2001 Sep; 912(2):176-80. PubMed ID: 11532434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N-methyl-D-aspartate receptors are involved in the quinolinic acid, but not in the malonate pro-oxidative activity in vitro.
    Puntel RL; Nogueira CW; Rocha JB
    Neurochem Res; 2005 Mar; 30(3):417-24. PubMed ID: 16018587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased severity of ethanol withdrawal behaviors in kainic acid-treated rats.
    Matsumoto I; Davidson M; Otsuki M; Wilce PA
    Pharmacol Biochem Behav; 1996 Nov; 55(3):371-8. PubMed ID: 8951978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Systemic administration of kainate induces marked increases of endogenous kynurenic acid in various brain regions and plasma of rats.
    Baran H; Gramer M; Hönack D; Löscher W
    Eur J Pharmacol; 1995 Nov; 286(2):167-75. PubMed ID: 8605953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 7-nitroindazole reduces nitrite concentration in rat brain after intrahippocampal kainate-induced seizure.
    Radenovic L; Vasiljevic I; Selakovic V; Jovanovic M
    Comp Biochem Physiol C Toxicol Pharmacol; 2003 Aug; 135(4):443-50. PubMed ID: 12965189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase.
    Chiarugi A; Carpenedo R; Moroni F
    J Neurochem; 1996 Aug; 67(2):692-8. PubMed ID: 8764597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tryptophan, adenosine, neurodegeneration and neuroprotection.
    Stone TW; Forrest CM; Mackay GM; Stoy N; Darlington LG
    Metab Brain Dis; 2007 Dec; 22(3-4):337-52. PubMed ID: 17712616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic DL-kynurenine and probenecid pretreatment attenuates quinolinic acid-induced neurotoxicity in rats.
    Santamaría A; Ríos C; Solís-Hernández F; Ordaz-Moreno J; González-Reynoso L; Altagracia M; Kravzov J
    Neuropharmacology; 1996 Jan; 35(1):23-8. PubMed ID: 8684593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential effects of calcium-dependent and calcium-independent phospholipase A(2) inhibitors on kainate-induced neuronal injury in rat hippocampal slices.
    Lu XR; Ong WY; Halliwell B; Horrocks LA; Farooqui AA
    Free Radic Biol Med; 2001 Jun; 30(11):1263-73. PubMed ID: 11368924
    [TBL] [Abstract][Full Text] [Related]  

  • 55. L-4-chlorokynurenine attenuates kainate-induced seizures and lesions in the rat.
    Wu HQ; Lee SC; Scharfman HE; Schwarcz R
    Exp Neurol; 2002 Sep; 177(1):222-32. PubMed ID: 12429224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Possible mediation of quinolinic acid-induced hippocampal damage by reactive oxygen species.
    Stone TW; Behan WM; MacDonald M; Darlington LG
    Amino Acids; 2000; 19(1):275-81. PubMed ID: 11026499
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kynurenines, Parkinson's disease and other neurodegenerative disorders: preclinical and clinical studies.
    Németh H; Toldi J; Vécsei L
    J Neural Transm Suppl; 2006; (70):285-304. PubMed ID: 17017544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kainic acid lesions enhance locomotor responses to novelty, saline, amphetamine, and MK-801.
    Bardgett ME; Jacobs PS; Jackson JL; Csernansky JG
    Behav Brain Res; 1997 Mar; 84(1-2):47-55. PubMed ID: 9079771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Memantine prevents quinolinic acid-induced hippocampal damage.
    Keilhoff G; Wolf G
    Eur J Pharmacol; 1992 Sep; 219(3):451-4. PubMed ID: 1425971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kynurenic acid influences the respiratory parameters of rat heart mitochondria.
    Baran H; Staniek K; Kepplinger B; Gille L; Stolze K; Nohl H
    Pharmacology; 2001 Feb; 62(2):119-23. PubMed ID: 11174083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.